3 completed, 2 not yet recruiting, 1 unknown. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Not yet recruiting 2, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Ocular Surface Disease: new trials by email Literature Review of Ocular Surface Disease trials Research Report on Ocular Surface Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive® PRO-240, Optive® - Dry Eye Disease, Dry Eye Sensation | Phase 1 | Not yet recruiting | Laboratorios Sophia S.A de C.V. | 32 | 2027-07-30 | 2026-11-10 |
| Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis Probiotic, Placebo Drug - Probiotic, Ocular Surface Disease | Phase 1 | Not yet recruiting | Mohsen Pourazizi | 32 | 2025-02-01 | 2025-01-27 |
| Efficacy and Safety of Topical Cyclosporine 0.05% and Lifitgrast on the Ocular Surface Symptom After Photorefractive Keratectomy in Feiz Hospital, Isfahan, 2024 Group 1 drug, Group 2: Drug and placebo, Group 3: Drug and palcebo - Ocular Surface Symptom, Ocular Surface Disease | Phase 1 | Unknown | Mohsen Pourazizi | 150 | 2024-10-30 | 2024-10-03 |
| Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF PRO-229, Lagricel® Ofteno PF - Dry Eye Disease, Ocular Surface Disease | Phase 1 | Completed | Laboratorios Sophia S.A de C.V. | 36 | 2024-05-16 | 2025-03-04 |
| Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE Device Restasis - Ocular Surface Disease | Phase 1 / Phase 2 | Completed | Boston Sight | 10 | 2021-07-15 | 2025-01-13 |
| A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers PP-001, Placebo - Keratoconjunctivitis, Ocular Surface Disease | Phase 1 | Completed | Panoptes Pharma GmbH | 45 | 2018-11-20 | 2024-01-12 |
Dry Eye Syndromes (2) · Conjunctivitis, Allergic (1) · Endophthalmitis (1) · Eye Pain (1) · Keratoconjunctivitis (1)
Eye Diseases (5) · Conjunctival Diseases (2) · Conjunctivitis (2) · Lacrimal Apparatus Diseases (2) · Corneal Diseases (1) · Eye Infections (1) · Eye Manifestations (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Infections (1) · Keratitis (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1)
CD5L protein, human (1) · Cyclosporins (1) · Pharmaceutical Preparations (1) · Probiotics (1)
Laboratorios Sophia S.A de C.V. (2) · Mohsen Pourazizi (2) · Boston Sight (1) · Panoptes Pharma GmbH (1)
Austria (1) · Iran (1) · Mexico (1) · United States (1)
Daniel C Brocks, MD (1) · Mohsen Pourazizi (1)